Quantum BioPharma gets FDA clearance for Lucid-MS phase 2 MS trial
Quantum BioPharma Ltd. (NASDAQ: QNTM, CSE: QNTM) announced that the U.S. Food and Drug Administration has cleared the company's Investigational ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
